The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France-Reference-Cited by-同舟云学术

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France

Published:2020-08 Issue:2 Volume:81 Page:318-356
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Dimeglio Chloé,Loubes Jean-Michel,Deporte Benjamin,Dubois Martine,Latour Justine,Mansuy Jean-Michel,Izopet Jacques

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference9 articles.

1. Another Decade, Another Coronavirus;Perlman;N. Engl. J. Med.,2020

2. WHO Virtual press conference on COVID-19—11 March 2020. https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2 (2020).

3. COVID-19 in Europe: the Italian lesson;Saglietto;Lancet,2020

4. The resilience of the Spanish health system against the COVID-19 pandemic;Legido-Quigley;Lancet,2020

5. Nowcasting and forecasting the potential domestic and international spread of the 2019-ncov outbreak originating in wuhan, china: a modelling study;Wu;Lancet,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 antibody among healthy blood donors in a hospital-based blood center in Eastern India during the COVID-19 pandemic;Asian Journal of Transfusion Science;2022

2. Seroprevalence of SARS-CoV-2 among Blood Donors in the Republic of Congo;Open Journal of Blood Diseases;2022

3. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics;Scientific Reports;2021-06-15

4. Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2;Viruses;2021-05-12

5. Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study;BMJ Open;2021-04